Evidence map›Paper›PMID 28804051›Full record

ArticleThe International journal on drug policy2017

Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.

Meghan D Morris, Torsten B Neilands, Erin Andrew, Lisa Maher, Kimberly A Page, Judith A Hahn

Registry-linked trialAbstract readValidation Study
In one paragraph

Article in The International journal on drug policy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07631559 (Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07631559 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs

TypeinterventionalSponsorUniversity of California, San FranciscoRan2026 to 2027Enrolled50ConditionsHEPATITIS C (HCV), Opioid Use Disorder, Substance Use Disorder (SUD), Drug Use DisordersArmsPartner navigation intervention booster session
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Meghan D MorrisDepartment of Epidemiology & Biostatistics, University of California San Francisco (UCSF), San Francisco, CA, USA. Electronic address: Meghan.Morris@ucsf.edu.
Torsten B NeilandsCenter for AIDS Prevention Studies, Department of Medicine, UCSF, San Francisco, CA USA.
Erin AndrewDepartment of Epidemiology & Biostatistics, University of California San Francisco (UCSF), San Francisco, CA, USA.
Lisa MaherKirby Institute, University of New South Wales, Sydney, Australia.
Kimberly A PageDepartment of Internal Medicine, University of New Mexico Health Center, Albuquerque, NM, USA.
Judith A HahnDepartment of Epidemiology & Biostatistics, University of California San Francisco (UCSF), San Francisco, CA, USA; Department of Medicine, UCSF, San Francisco, CA, USA.

Funding

Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
Acute Hepatitis C Infection in Young InjectorsR01DA016017 · NIDA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PAGE, KIMBERLY · 2002 to 2018
$14.0M
Clinical and Transtional Science InstituteKL2TR000143 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$11.9M
Training in Research Program on Alcohol Use by Persons with our at Risk for HIVK24AA022586 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2013 to 2023
$1.8M
Understanding the interpersonal context of HIV/HCV risk within injecting dyadsK01DA037802 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MORRIS, MEGHAN D · 2014 to 2018
$913k
NCATS NIH HHS KL2 TR000143NIAAA NIH HHS K24 AA022586NIDA NIH HHS K01 DA037802NIDA NIH HHS R01 DA016017NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

backgroundPeople who inject drugs with sexual partners or close friends have high rates of syringe/ancillary equipment sharing and HIV and hepatitis C virus (HCV) infection. Although evidence suggests that interpersonal factors underlie these higher risk profiles, there is no quantitative measure of how interpersonal factors operate within injecting relationships. We aimed to develop and validate a quantitative scale to assess levels of injecting drug-related interpersonal factors associated with risky injecting behaviours within injecting partnerships.

methodsWe conducted qualitative interviews with 45 people who inject drugs (PWID) who reported having injecting partners to inform item development, and tested these items in a quantitative study of 140 PWID from San Francisco, USA, to assess internal reliability (Cronbach's alpha) and validity (convergent, and discriminant validity).

resultsWith results from the qualitative interview data, we developed the Interpersonal Dynamics in Injecting Partnerships (IDIP) scale with 54 final items for 5 subscales of injecting-related interpersonal factors. Exploratory factor analysis revealed 5 factors ("trust", "power", "risk perception", "intimacy", and "cooperation") with eigenvalues of 14.32, 6.18, 3.55, 2.46, and 2.14, explaining 57% of the variance, and indicating good internal reliability (alpha: 0.92-0.68). Strong convergent validity was observed in bivariate logistic regression models where higher levels of trust, intimacy, and cooperation within partnerships were positively associated with partners sharing needles and injecting equipment, whereas higher levels of power and risk perception were negatively associated with partners sharing needles and injecting equipment.

conclusionsThese findings offer strong evidence that the IDIP scale provides a psychometrically sound measure of injecting drug-related interpersonal dynamics. This measurement tool has the potential to facilitate additional investigations into the individual and collective impact of trust, intimacy, power, cooperation, and risk perception on injection drug using behaviours and engagement in HIV and HCV testing and treatment among PWID in a variety of settings.

Indexed as

AdultDrug UsersFactor Analysis, StatisticalFemaleFriendsHepatitis CHIV InfectionsHumansInterviews as TopicMaleNeedle SharingReproducibility of ResultsRisk-TakingSan FranciscoSexual BehaviorSexual PartnersDyadHCVInjecting partnershipsInjection drug useScale development

Identifiers

PMID28804051
PMCPMC5652066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.